Cat.#: ACPP-1537
| Despition | YY1 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 80.0% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1485 | Rat VEGF C Protein (152 a.a.) (AC1485) | 2 µg | inquiry |
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1505 | Human CRYGD Protein (AC1505) | 5 µg | inquiry |
| ACPP-1143 | Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) (AC1143) | 50 µg | inquiry |
| ACPP-1510 | Human TIMP1 Protein, Sf9 (AC1510) | 2 µg | inquiry |
| ACPP-1625 | Human POMC Protein (AC1625) | 2 µg | inquiry |
| ACPP-1054 | Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) | 50 µg | inquiry |
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
| ACPP-1520 | Mouse PSPN Protein (AC1520) | 5 µg | inquiry |
| ACPP-1390 | Human GDF11 Protein, His (AC1390) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.